Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540773 · ClinicalTrials.gov registry record · NA
Single Low-Dose of Supplement Amino Acid
A NA study of Growth Hormone and Amino Acid, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01540773 is a NA study of Growth Hormone and Amino Acid that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01540773, a NA study of Growth Hormone and Amino Acid, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Amino acid supplement
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01540773
The ClinicalTrials.gov registry entry for NCT01540773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Growth Hormone appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01540773 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT01540773 about?
NCT01540773 is a clinical study titled "Single Low-Dose of Supplement Amino Acid". The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.
What is the current status of trial NCT01540773?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2012-03.
What conditions does trial NCT01540773 study?
This clinical trial studies the following conditions: Growth Hormone, Amino Acid.
What interventions are being tested in trial NCT01540773?
The interventions under investigation include: Placebo (DRUG), Amino acid supplement (DRUG).
Who is sponsoring clinical trial NCT01540773?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01540773 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Hormone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.